APS-03118

N/A

Report date: 2026/03/31 20:00:21
NME

Base Information

Drug NameAPS-03118
Drug Alias NameAPS-03118APS03118
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase receptor RET inhibitors
TargetsTyrosine-protein kinase receptor RET
Therapy Area/IndicationsMedullary thyroid cancer (MTC)Solid tumoursNeoplasm Metastasis +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesApplied Pharmaceutical Science Inc
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesApplied Pharmaceutical Science Inc
Inactive CompaniesN/A
Active IndicationsMedullary thyroid cancer (MTC)Solid tumoursNeoplasm Metastasis +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A